Internal Medicine, Nephrology · Brooklyn, NY
NPI
1942259205
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
894 Eastern Pkwy
Brooklyn, NY, 11213
Phone (516) 450-0701
Groups this clinician bills Medicare through
Medicare paid, 2024
$216K
2,822 services
Medicare patients, 2024
245
Average age 74
Drug cost, 2024
$1.3M
9,192 prescriptions
Company payments, 2025
$197
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ankineedu Prasad was code 99214 (office e&m - established), 442 times for 116 patients. In total Ankineedu Prasad billed 2,822 services in 40 codes, and Medicare paid $216K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 442 | 116 | $104.43 | $46K |
| 99233 Hospital E&M - Subsequent | Facility | 283 | 51 | $104.75 | $30K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 242 | 42 | $54.52 | $13K |
| 36410 Vascular | Office | 223 | 111 | $14.47 | $3,227 |
| 99232 Hospital E&M - Subsequent | Facility | 220 | 41 | $68.00 | $15K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 219 | 38 | $41.54 | $9,097 |
| 99441 Telephone Services | Office | 205 | 80 | $46.51 | $9,534 |
| 99457 E&M - Miscellaneous | Office | 113 | 11 | $44.08 | $4,981 |
| 99454 E&M - Miscellaneous | Office | 104 | 11 | $44.06 | $4,582 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 103 | 103 | $28.16 | $2,901 |
| 90960 ESRD Related Services (not dialysis) | Office | 102 | 27 | $307.31 | $31K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 59 | 59 | $21.70 | $1,280 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 57 | 57 | $147.24 | $8,393 |
| 99213 Office E&M - Established | Office | 56 | 38 | $75.84 | $4,247 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 40 | 40 | $21.76 | $870 |
By year: 2022 $557K for 6,468 services; 2023 $406K for 4,406 services; 2024 $216K for 2,822 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ankineedu Prasad prescribed most often to Medicare patients was Atorvastatin Calcium, with 727 prescriptions and refills. In total Ankineedu Prasad wrote 9,192 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 727 | 1,913 | 250 | $7,778 |
| Amlodipine Besylate Generic | 667 | 1,821 | 222 | $4,963 |
| Nifedipine Er Nifedipine | 419 | 1,061 | 141 | $16K |
| Metformin Hcl Generic | 354 | 942 | 122 | $2,777 |
| Losartan Potassium Generic | 318 | 833 | 100 | $3,661 |
| Metoprolol Succinate Generic | 276 | 682 | 94 | $3,735 |
| Rosuvastatin Calcium Generic | 244 | 649 | 84 | $5,327 |
| Jardiance Empagliflozin | 237 | 557 | 78 | $317K |
| Valsartan Generic | 230 | 569 | 83 | $5,917 |
| Furosemide Generic | 218 | 541 | 80 | $985 |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 211 | 564 | 75 | $8,796 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 164 | 396 | 50 | $3,668 |
| Kerendia Finerenone | 158 | 330 | 53 | $206K |
| Farxiga Dapagliflozin Propanediol | 154 | 284 | 53 | $153K |
| Calcitriol Generic | 154 | 378 | 60 | $3,610 |
Brand drugs: 1,357 claims; generic drugs: 7,713 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ankineedu Prasad $197 ($197 in general payments such as food, travel and fees) from 3 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $117.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.